Farrer David G, Hueber Sara, Laiosa Michael D, Eckles Kevin G, McCabe Michael J
Department of Environmental Medicine, School of Medicine and Dentistry, University of Rochester Rochester, NY, USA.
Toxicol Appl Pharmacol. 2008 Jun 1;229(2):135-45. doi: 10.1016/j.taap.2007.12.011. Epub 2008 Apr 22.
The persistent environmental toxicant and immunomodulator, lead (Pb), has been proposed to directly target CD4(+) T cells. However, our studies suggest that CD4(+) T cells are an important functional, yet indirect target. In order to identify the direct target of Pb in the immune system and the potential mechanism of Pb-induced immunotoxicity, myeloid suppressor cells (MSCs) were evaluated for their ability to modulate CD4(+) T cell proliferation after Pb exposure. Myeloid suppressor cells regulate the adaptive immune response, in part, by inhibiting the proliferation of CD4(+) T cells. It is thought that the mechanism of MSC-dependent regulation involves the release of the bioactive gas, nitric oxide (NO), blocking cell signaling cascades downstream of the IL-2 receptor and thus preventing T cells from entering cell-cycle. In mixed lymphocyte culture (MLC), increasing numbers of MSCs suppressed T cell proliferation in a dose-dependent manner, and this suppression is strikingly abrogated with 5 microM lead (Pb) treatment. The Pb-sensitive MSC population is CD11b(+), GR1(+)and CD11c(-) and thus phenotypically consistent with MSCs described in other literature. Inhibition of NO-synthase (NOS), the enzyme responsible for the production of NO, enhanced alloreactive T cell proliferation in MLC. Moreover, Pb attenuated NO production in MLC, and exogenous replacement of NO restored suppression in the presence of Pb. Significantly, MSC from iNOS-/- mice were unable to suppress T cell proliferation. An MSC-derived cell line (MSC-1) also suppressed T cell proliferation in MLC, and Pb disrupted this suppression by attenuating NO production. Additionally, Pb disrupted NO production in MSC-1 cells in response to treatment with interferon-gamma (IFN-gamma) and LPS or in response to concanavalin A-stimulated splenocytes. However, neither the abundance of protein nor levels of mRNA for the inducible isoform of NOS (iNOS) were altered with Pb treatment. Taken together these data suggest that Pb abrogates an MSC-dependent suppression of alloreactive T cell proliferation by inhibiting the function, but not the expression of iNOS.
持久性环境毒物及免疫调节剂铅(Pb)被认为可直接作用于CD4(+) T细胞。然而,我们的研究表明,CD4(+) T细胞是一个重要的功能性但间接的靶点。为了确定铅在免疫系统中的直接靶点以及铅诱导免疫毒性的潜在机制,我们评估了髓系抑制细胞(MSC)在铅暴露后调节CD4(+) T细胞增殖的能力。髓系抑制细胞部分通过抑制CD4(+) T细胞的增殖来调节适应性免疫反应。据认为,MSC依赖性调节机制涉及生物活性气体一氧化氮(NO)的释放,阻断IL-2受体下游的细胞信号级联反应,从而阻止T细胞进入细胞周期。在混合淋巴细胞培养(MLC)中,MSC数量增加以剂量依赖性方式抑制T细胞增殖,而5微摩尔铅(Pb)处理可显著消除这种抑制作用。对铅敏感的MSC群体为CD11b(+)、GR1(+)和CD11c(-),因此其表型与其他文献中描述的MSC一致。抑制负责产生NO的一氧化氮合酶(NOS)可增强MLC中同种异体反应性T细胞的增殖。此外,铅可减弱MLC中NO的产生,在存在铅的情况下,外源性补充NO可恢复抑制作用。重要的是,来自诱导型一氧化氮合酶基因敲除(iNOS-/-)小鼠的MSC无法抑制T细胞增殖。一种源自MSC的细胞系(MSC-1)在MLC中也可抑制T细胞增殖,而铅通过减弱NO的产生破坏了这种抑制作用。此外,铅可破坏MSC-1细胞在受到干扰素-γ(IFN-γ)和脂多糖(LPS)处理或受到刀豆蛋白A刺激的脾细胞刺激时产生NO的能力。然而,铅处理并未改变诱导型一氧化氮合酶(iNOS)的蛋白丰度或mRNA水平。综合这些数据表明,铅通过抑制iNOS的功能而非表达,消除了MSC对同种异体反应性T细胞增殖的依赖性抑制作用。